RGNX
#2797
REGENXBIO Inc. - Common Stock
9.3 7 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.11%
Monthly Change
-2.90%
6 month change
+7.58%
Year Change
-30.23%
Previous Close
9.3 8
Open
9.3 7
Low
9.3 7
High
9.3 7
Volume
67
Financials
- Market Capitalization 618.54 M
- Employee 371
- Founded 2008
- CEO N/A
- Website www.regenxbio.com
- Headquarter Maryland, United States
- FIGI BBG007Z9V591
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.83
Price to sales ratio
4.36
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2784 |  ALT Altimmune, Inc. - Common Stock | 3.24 USD | +2.86% | +8.72% | +8.00% | -12.90% | 630.24 M USD | ||
| 2788 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 2.36 USD | +1.29% | -3.28% | +62.76% | +49.37% | 628.14 M USD | ||
| 2814 |  ARVN Arvinas, Inc. - Common Stock | 9.24 USD | -0.86% | +2.44% | +12.96% | -0.65% | 604.17 M USD | ||
| 2820 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 6.03 USD | 0.00% | +9.24% | +7.68% | -34.53% | 599.67 M USD |
Frequently asked questions about REGENXBIO Inc.
What is the REGENXBIO Inc. stock price today?
The current price of REGENXBIO Inc. (RGNX) is 9.37. Over the past 24 hours, the stock has changed by -0.11%. Follow the RGNX chart for real-time price dynamics.
What is the stock ticker of REGENXBIO Inc.?
REGENXBIO Inc. trades under the ticker RGNX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is REGENXBIO Inc. stock going up?
RGNX has changed by -15.89% over the last week, -2.90% over the last month, and -30.23% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of REGENXBIO Inc.?
REGENXBIO Inc. currently has a market capitalization of 618.54 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were REGENXBIO Inc. earnings last quarter?
Last quarter, REGENXBIO Inc. reported earnings of 0.43 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was REGENXBIO Inc. revenue for the last quarter?
REGENXBIO Inc. reported quarterly revenue of 108.02 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was REGENXBIO Inc. net income for the last quarter?
REGENXBIO Inc. reported net income of 22.71 M for the last quarter. The previous quarter showed -90.05 M, which means net income changed by +125.22%.
How many employees does REGENXBIO Inc. have?
As of the latest available data, REGENXBIO Inc. has 371 employees. Workforce size can provide additional context about the company's scale and operations.
What is REGENXBIO Inc. EBITDA?
REGENXBIO Inc. EBITDA is 28.82 M, and its EBITDA margin is 26.68%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy REGENXBIO Inc. stock?
You can buy REGENXBIO Inc. (RGNX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in REGENXBIO Inc. stock?
Investing in REGENXBIO Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RGNX chart and related analysis on metatrader.com as part of your research.